Men Clinical Trials

4,772 recruitingLast updated: June 21, 2026

There are 4,772 actively recruiting men clinical trials across 126 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Boston, Massachusetts, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Men Trials at a Glance

4,772 actively recruiting trials for men are listed on ClinicalTrialsFinder across 6 cities in 126 countries. The largest study group is Not Applicable with 2,390 trials, with the heaviest enrollment activity in New York, Boston, and Chicago. Lead sponsors running men studies include Cairo University, Massachusetts General Hospital, and Johns Hopkins University.

Treatments under study

About Men Clinical Trials

Looking for clinical trials for Men? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Men trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Men clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 4,772 trials

Recruiting
Phase 2

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis

Focal Segmental Glomerulosclerosis
National Human Genome Research Institute (NHGRI)30 enrolled1 locationNCT06664814
Recruiting

Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

InfertilityAcute Ovarian FailureEarly Menopause And Infertility In Females After Treatment For Childhood Cancer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)100 enrolled1 locationNCT05440617
Recruiting
Not Applicable

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

Leptomeningeal Disease
M.D. Anderson Cancer Center40 enrolled1 locationNCT07415018
Recruiting

Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy

Turner SyndromeGalactosemiaPost-menarcheal Adolescents+3 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)200 enrolled1 locationNCT04948658
Recruiting
Not Applicable

Multidimensional Sleep Health Intervention to Optimize Concussion Recovery

TreatmentDepression, AnxietySleep Health+2 more
University of Colorado, Denver54 enrolled1 locationNCT07082218
Recruiting

Inherited Reproductive Disorders

InfertilityHypogonadismAmenorrhea+1 more
National Institute of Environmental Health Sciences (NIEHS)850 enrolled2 locationsNCT01500447
Recruiting

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Cryptococcal MeningitisWartsIdiopathic CD4+ Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID)950 enrolled1 locationNCT00867269
Recruiting
Phase 1

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

HealthyMild Cognitive ImpairmentAlzheimer s Disease
National Institute of Mental Health (NIMH)90 enrolled1 locationNCT07169630
Recruiting

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Amyotrophic Lateral SclerosisFrontotemporal DementiaProgressive Supranuclear Palsy
National Institute of Neurological Disorders and Stroke (NINDS)360 enrolled1 locationNCT03225144
Recruiting
Phase 4

Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis

Clonal Hematopoiesis of Indeterminate PotentialColchicineCoronary Atherosclerosis Management
Shenyang Northern Hospital120 enrolled1 locationNCT07362966
Recruiting

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

SleepNeurodevelopmental DisorderNeurological Disorder+1 more
National Institute of Mental Health (NIMH)1,000 enrolled1 locationNCT01778504
Recruiting
Not Applicable

Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

Mild Cognitive Impairment
Société des Produits Nestlé (SPN)380 enrolled28 locationsNCT06347315
Recruiting

Genetic Characterization of Movement Disorders and Dementias

DementiaMovement Disorder
National Institute on Aging (NIA)12,000 enrolled1 locationNCT02014246
Recruiting

Fungal Infection Susceptibility

Cryptococcal MeningitisCryptococcosisCryptococcal Infection+2 more
National Institute of Allergy and Infectious Diseases (NIAID)800 enrolled1 locationNCT00001352
Recruiting
Not Applicable

Hemodynamics After Resistance Training

Perimenopause
University of Michigan50 enrolled1 locationNCT07022340
Recruiting
Phase 2

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRefractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+12 more
National Cancer Institute (NCI)120 enrolled84 locationsNCT06649812
Recruiting
Not Applicable

Pre-incisional Infiltration With Ropivacaine Plus Diprospan for Relieving Postoperative Pain After Thoracoscopic Surgery

Video-assisted Thoracoscopic Surgery (VATS)SegmentectomyLobectomy+2 more
Beijing Tiantan Hospital100 enrolled1 locationNCT07626489
Recruiting
Not Applicable

The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment

Type 2 Diabetes Mellitus (T2DM)Mild Cognitive Impairment (MCI)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School40 enrolled1 locationNCT07650318
Recruiting
Phase 1

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaAcute Myeloid Leukemia With KMT2A Rearrangement+1 more
National Cancer Institute (NCI)38 enrolled22 locationsNCT05886049
Recruiting
Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

DementiaALSMild Cognitive Impairment+2 more
National Institute of Mental Health (NIMH)184 enrolled1 locationNCT04396873